1
Alec D Keith, Wallace C Snipes: Buccal drug dosage form. Zetachron, Vorys Sater Seymour & Pease, August 16, 1988: US04764378 (206 worldwide citation)

Buccal dosage forms for transmucosal administration of drugs comprise a pharmaceutical compound dispersed in an erodible matrix comprising


2
Wallace C Snipes, Stephen J Wagner: Erodible matrix for sustained release bioactive composition. Zetachron, Vorys Sater Seymour and Pease, February 21, 1989: US04806337 (148 worldwide citation)

A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises said biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of (a.) 5% to 95% by weight of a solid water-dispersible polyether diol havin ...


3
Wallace C Snipes: Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith. Zetachron, Vorys Sater Seymour & Pease, April 2, 1991: US05004601 (91 worldwide citation)

An exicipient for a pharmaceutical compound which melts at body temperature but will not spontaneously deform at higher temperatures encountered in shipment and storage comprises:


4
Wallace C Snipes, Stephen J Wagner: Erodible matrix for sustained release bioactive composition. Zetachron, Vorys Sater Seymour and Pease, May 17, 1988: US04744976 (79 worldwide citation)

A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises the biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of


5
Wallace C Snipes: Erodible matrix for sustained release bioactive composition. Zetachron, Vorys Sater Seymour and Pease, December 16, 1986: US04629621 (63 worldwide citation)

A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises said biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of


6
Wallace C Snipes: Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith. Zetachron, Vorys Sater Seymour & Pease, August 18, 1992: US05139790 (61 worldwide citation)

An excipient for a pharmaceutical compound which melts at body temperature but will not spontaneously deform at higher temperatures encountered in shipment and storage comprises:


7
Wallace C Snipes: Buccal dosage form. Zetachron, Vorys Sater Seymour & Pease, August 4, 1992: US05135752 (58 worldwide citation)

A matrix for a buccal dosage form which melts in the oral cavity at body temperature but will not spontaneously deform at higher temperatures encountered in shipment and storage comprises:


8
Wallace C Snipes, Neena Agarwala: Pharmaceutical composition for drugs subject to supercooling. Zetachron, Vorys Sater Seymour & Pease, January 21, 1992: US05082655 (52 worldwide citation)

A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises a biologically active compound dispersed in a matrix which progressively erodes in contact with a liquid environment, the matrix having a melting point below the melting point of ...


9
Wallace C Snipes: Erodible matrix for sustained release bioactive composition. Zetachron, Vorys Sater Seymour and Pease, September 27, 1988: US04774074 (51 worldwide citation)

A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises said biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of


10
Wallace C Snipes: Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith. Zetachron, Vorys Sater Seymour & Pease, September 14, 1993: US05244668 (25 worldwide citation)

An excipient for a pharmaceutical compound which melts at body temperature but will not spontaneously deform at higher temperatures encountered in shipment and storage comprises: